Quantum Genesis AI Corp. (QGAI)

Market Cap	18.03M
Revenue (ttm)	n/a
Net Income	-4.49M
EPS	-0.12
Shares Out	40.97M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,800
Open	0.4400
Previous Close	0.4500
Day's Range	0.4300 - 0.4400
52-Week Range	0.0011 - 5.0400
Beta	8.08
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 16, 2026

About Quantum Genesis AI

Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Quantumzyme Corp. and changed its name to Quantum Genesis AI Corp. in February 2026. Quantum Genesis AI Corp. w...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2015
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: QGAI